Eurobio Scientific

Eurobio Scientific

ALERS.PAPre-clinical
Les Ulis, FranceFounded 1997eurobio-scientific.com

Eurobio Scientific is a French specialty diagnostics leader that develops, manufactures, and commercializes a broad portfolio of molecular diagnostic tests and life science products. Its core business segments include oncology (with prognostic genomic tests), infectious diseases, transplantation, and life sciences (cell culture media, ELISA kits, quality controls). The company has established itself as a significant player in the European diagnostics market through both proprietary innovation and strategic partnerships, serving clinical laboratories and research institutions globally.

Market Cap
$248.6M
Founded
1997
Focus
Diagnostics

ALERS.PA · Stock Price

USD 21.40+3.76 (+21.32%)

Historical price data

AI Company Overview

Eurobio Scientific is a French specialty diagnostics leader that develops, manufactures, and commercializes a broad portfolio of molecular diagnostic tests and life science products. Its core business segments include oncology (with prognostic genomic tests), infectious diseases, transplantation, and life sciences (cell culture media, ELISA kits, quality controls). The company has established itself as a significant player in the European diagnostics market through both proprietary innovation and strategic partnerships, serving clinical laboratories and research institutions globally.

Technology Platform

The company's core technology involves molecular diagnostics, including prognostic genomic testing for cancer, genetic testing for infectious diseases and other conditions, ELISA-based immunoassays, and the production of life science research reagents like cell culture media.

Funding History

1
IPOUndisclosedUndisclosedJun 15, 2005

Opportunities

Growth opportunities include expanding its portfolio of proprietary prognostic genomic tests into new cancer types, leveraging its distribution network to bring more partner products to market, and geographic expansion outside of Europe.
The growing demand for personalized medicine and decentralized testing also presents significant tailwinds.

Risk Factors

Key risks include intense competition from larger global diagnostics firms, regulatory hurdles for new test approvals, dependence on reimbursement policies, and the potential for technological disruption from next-generation sequencing and AI-driven diagnostics.

Competitive Landscape

Eurobio Scientific competes with large multinational diagnostics companies (Roche, Abbott, Siemens, bioMérieux) and niche players in specific segments like Myriad Genetics (oncology genomics) and Qiagen (molecular diagnostics). Its differentiation lies in its specialized focus, combined proprietary/distributor model, and strong regional presence in Europe.

Company Info

TypeDiagnostics
Founded1997
LocationLes Ulis, France
StagePre-clinical
RevenueRevenue Generating

Trading

TickerALERS.PA
ExchangeEuronext Paris

Therapeutic Areas

OncologyInfectious DiseasesTransplantationFertilityDermatologyAuto-immunityAllergy

Partners

Supplier & Distribution partners (unnamed)
SIMILAR COMPANIES
4P-Pharma
4P-Pharma
Phase 2 · Lille
Patheon
Patheon
Pre-clinical · Lyon
ABL Diagnostics
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Adjuvatis
Pre-clinical · Lyon
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile